Description
The Key Products in this segment include vitamin supplements & vitamin combination specialized products capable of handling problems of diabetes, arthritis, neurological issues & cardiac ailments. The company’s key brands includes the the multivitamin segment (inject able, oral and suspension), eye drop segment, each of which has significant opportunity of USD 117 billion (Rs. 5,148 billion). The Nutraceuticals market has been growing at a CAGR of 15% for the last 3 years. The Ernst & Young FICCI Report estimates the latent market in India at 2-4 times the existing market size (between Rs. 89 billion and Rs. 172 billion) with nearly 148 million potential customers.